
Publication
Giurisprudenza | MedMal
MedMal: obbligo di nomina del collegio peritale nei giudizi di responsabilità medica
Singapore | Publication | agosto 2025
On 1 April 2025, the Transport Sector (Critical Firms) Act (the Act) was passed in Parliament after being introduced by the Ministry of Transport in Parliament on 3 April 2024. The Act aims to enhance the resilience of essential transport services in Singapore and to protect against the risk of external parties exerting undue influence over such services, and in doing so expands the list of sectors in Singapore with sectoral legislation which impose ownership and control restrictions.
A central component of the Act is its introduction of a designated entities regime, under which entities across air, land and sea sectors can be designated by relevant authorities (i.e. the Civil Aviation Authority of Singapore, the Land Transport Authority of Singapore and the Maritime and Port Authority of Singapore, each an Authority) under their respective sectoral legislation if they are key entities involved in the provision of essential transport services in Singapore (Designated Entities). Such Designated Entities will either be designated as a “designated operating entity” if they directly provide essential transport services in Singapore, or a “designated equity interest holder” if they hold equity interest in a designated operating entity.
The following entities have presently been designated as Designated Entities:
(i) Designated operating entities
(ii) Designated equity interest holders
The new designated entities regime under the Act supplements the list of sectors subject to legislative restrictions on ownership and control – the current regulated sectors include the telecommunications, banking and utilities industries, where investors are required to seek specific approvals and/or licences from the relevant sector regulators.
The Act establishes a framework for monitoring and regulating ownership changes in Designated Entities through amendments to the statutes administered by the Authorities, namely the Bus Services Industry Act 2015, the Civil Aviation Authority of Singapore Act 2009, the Maritime and Port Authority of Singapore Act 1996 and the Rapid Transit Systems Act 1995. Pursuant to the Act (and its corresponding amendments to the foregoing statutes):
(i) prospective investors into Designated Entities are required to:
(ii) Designated Entities must notify the relevant Authority within seven (7) days upon becoming aware of any of the above changes.
Where a transaction is effected without the necessary approval, the transacting parties may be directed by the relevant Authority to remedy the non-compliance, such as disposing of a stake in the Designated Entity.
Designated Entities will also be subject to other controls, including that:
The Act introduces a regulatory framework designed to ensure that significant changes in ownership of Designated Entities are subject to government scrutiny and approval. While the Act aims to protect critical infrastructure, businesses and investors should be aware of the following:
The Act follows closely on the heels of the introduction of the Significant Investments Review Act 2024 (more information on the Significant Investments Review Act 2024 has been covered in our article: Proposed Statutory Developments in Singapore’s Foreign Direct Investment Regime – Significant Investments Review Bill), potentially signalling a trend toward greater regulatory scrutiny of M&A deals. Businesses and investors operating within or engaging with Designated Entities in the transport sector should familiarise themselves with the Act to navigate its requirements effectively and ensure compliance.
Additionally, where deals involving Designated Entities are concerned, we expect a potential uptick in deal structures where Designated Entities enter into unincorporated arrangements, such as partnerships and contractual joint ventures. To the extent that such arrangements do not fall within the scope of the Act, this approach allows Designated Entities to preserve their equity structures and maintain control over their operations, while collaborating with third parties and sharing both economic risks and profits.
Publication
MedMal: obbligo di nomina del collegio peritale nei giudizi di responsabilità medica
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025